When should a cosmetic project be stopped after sample testing?
Direct Answer
A cosmetic project should be stopped after sample testing when repeated failures reveal unresolved stability, packaging, filling, or scale-up risk boundaries.
Decision Interpretation
Stopping a project after sample testing is a manufacturing decision, not a negative outcome by itself. It can prevent larger production loss when sample signals show structural mismatch.
The focus is stop conditions, which means the sample result must be translated into a manufacturing decision before the project moves closer to procurement readiness.
Manufacturing Risk Framing
Stop conditions include repeated instability, incompatible packaging, unmanageable filling behavior, unacceptable batch variation, or production constraints that cannot be corrected within the project boundary.
This risk should be reviewed as part of the sample-to-production bridge, where sample evidence is tested against actual production constraints.
What to evaluate next
The next decision is whether to stop, redesign, reformulate, change packaging, or restart validation with a corrected manufacturing pathway.
The purpose is to decide the manufacturing direction, not to treat the sample result as a final commercial decision.
Decision System Link
Decision Closure Layer
This page belongs to the sample-to-procurement bridge because it converts sample-stage evidence into manufacturing decision direction before procurement readiness is assumed.
No sample result should be interpreted alone. It should be checked against scale-up risk, packaging compatibility, filling behavior, stability expectations, and production readiness boundaries.